drugset / Trial / NCT00750308

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

NCT00750308

RandomizedCrossoverQuadruple-blindBasic science

Summary

This study will measure the effect of the agent tadalafil on glucose and insulin homeostasis in people with metabolic syndrome in the presence and absence of an ACE inhibitor.

Timeline

Start
2006-12
Primary completion
2009-01
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ramipril Small molecule 10 mg
Comparator Tadalafil Small molecule 10 mg

Indications